SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wen Zhibo)
 

Sökning: WFRF:(Wen Zhibo) > Dynamic contrast-en...

Dynamic contrast-enhanced CEST MRI using a low molecular weight dextran

Han, Zheng (författare)
Kennedy Krieger Institute,Johns Hopkins University
Chen, Chuheng (författare)
Case Western Reserve University
Xu, Xiang (författare)
Kennedy Krieger Institute,Johns Hopkins University
visa fler...
Bai, Renyuan (författare)
Johns Hopkins University
Staedtke, Verena (författare)
Johns Hopkins University
Huang, Jianpan (författare)
City University of Hong Kong
Chan, Kannie W Y (författare)
City University of Hong Kong,Johns Hopkins University
Xu, Jiadi (författare)
Kennedy Krieger Institute,Johns Hopkins University
Kamson, David O (författare)
Johns Hopkins University
Wen, Zhibo (författare)
Southern Medical University
Knutsson, Linda (författare)
Lund University,Lunds universitet,MR Physics,Forskargrupper vid Lunds universitet,Lund University Research Groups,Johns Hopkins University
van Zijl, Peter C M (författare)
Johns Hopkins University,Kennedy Krieger Institute
Liu, Guanshu (författare)
Johns Hopkins University,Kennedy Krieger Institute
visa färre...
 (creator_code:org_t)
2021-11-15
2022
Engelska.
Ingår i: NMR in Biomedicine. - : Wiley. - 0952-3480 .- 1099-1492. ; 35:3
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Natural and synthetic sugars have great potential for developing highly biocompatible and translatable chemical exchange saturation transfer (CEST) MRI contrast agents. In this study, we aimed to develop the smallest clinically available form of dextran, Dex1 (molecular weight, MW ~ 1 kDa), as a new CEST agent. We first characterized the CEST properties of Dex1 in vitro at 11.7 T and showed that the Dex1 had a detectable CEST signal at ~1.2 ppm, attributed to hydroxyl protons. In vivo CEST MRI studies were then carried out on C57BL6 mice bearing orthotopic GL261 brain tumors (n = 5) using a Bruker BioSpec 11.7 T MRI scanner. Both steady-state full Z-spectral images and single offset (1.2 ppm) dynamic dextran-enhanced (DDE) images were acquired before and after the intravenous injection of Dex1 (2 g/kg). The steady-state Z-spectral analysis showed a significantly higher CEST contrast enhancement in the tumor than in contralateral brain (∆MTRasym 1.2 ppm = 0.010 ± 0.006 versus 0.002 ± 0.008, P = 0.0069) at 20 min after the injection of Dex1. Pharmacokinetic analyses of DDE were performed using the area under the curve (AUC) in the first 10 min after Dex1 injection, revealing a significantly higher uptake of Dex1 in the tumor than in brain tissue for tumor-bearing mice (AUC[0-10 min] = 21.9 ± 4.2 versus 5.3 ± 6.4%·min, P = 0.0294). In contrast, no Dex1 uptake was foundling in the brains of non-tumor-bearing mice (AUC[0-10 min] = -1.59 ± 2.43%·min). Importantly, the CEST MRI findings were consistent with the measurements obtained using DCE MRI and fluorescence microscopy, demonstrating the potential of Dex1 as a highly translatable CEST MRI contrast agent for assessing tumor hemodynamics.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
NATURVETENSKAP  -- Fysik -- Annan fysik (hsv//swe)
NATURAL SCIENCES  -- Physical Sciences -- Other Physics Topics (hsv//eng)

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy